Treatment options

Surgery

There are two types of surgery depending on the goal of treatment. If the tumor is small enough and has not spread into major blood vessels, there is a chance it can all be removed (resected). If the cancer is too widespread, surgery may be palliative — to relieve symptoms or prevent future problems.

Radiation therapy

Radiation uses high-energy rays to kill or shrink cancer cells. Treatment is usually given several times a week for weeks or months, sometimes before surgery and sometimes after. It is often combined with chemotherapy when tumors cannot be removed. Side effects can include skin changes, upset stomach, loose bowels, or tiredness.

Chemotherapy

Chemotherapy uses drugs — given by vein or as a pill — that travel through the bloodstream. Gemcitabine is commonly used when pancreatic cancer has spread. Temporary side effects may include nausea, loss of appetite, hair loss, mouth sores, fatigue, and low blood counts. Complementary therapies often target these side effects.

Resectable, borderline, locally advanced, and metastatic

Surgeons usually consider pancreatic cancer resectable if it looks contained in the pancreas. A Whipple procedure (pancreaticoduodenectomy) or distal pancreatectomy may be performed. For people who have surgery to completely remove cancer of the exocrine pancreas, the 5-year survival rate is about 20%.

Borderline resectable cancers often receive neoadjuvant chemotherapy first to shrink the tumor. Locally advanced cancers have grown too far into nearby vessels to be removed completely; chemotherapy, sometimes followed by chemoradiation, is standard. Metastatic disease is treated primarily with chemotherapy; in some cases immunotherapy or targeted therapy may be options when specific genetic markers are present.

Survival context

Overall, about 8–13% of patients with cancer of the exocrine pancreas will be alive 5 years after the cancer is found, depending on stage. Local disease has a higher relative survival; distant disease is near 3%. These numbers are an overall picture — they cannot predict exactly what will happen in any one case.

This information is educational, not medical advice. Ask your oncology team about trials, second opinions, and palliative support early — not only at the end of the road.